Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
LYS-GM101 / Lysogene
2019-004949-32: LYS-GM101 gene therapy trial in patients with GM1 gangliosidosis	Not yet recruiting	1/2	18	Europe	LYS-GM101, LYS-GM101, Suspension for injection	Lysogene, Lysogene SA	GM1 gangliosidosis, GM1 gangliosidosis, Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
NCT04273269 / 2019-004949-32: A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 Gangliosidosis	Terminated	1/2	5	Europe, US	LYS-GM101	LYSOGENE, Lysogene SA	GM1 Gangliosidosis	05/23	05/23